Nanotechnology is not science fiction|
| || ||
Economic Development - The Toronto Biotechnology Initiative (TBI) hosted a
seminar today featuring a discussion on the biological applications of
nanotechnology - the convergence of chemistry, biology and physics to enable us
to do things such as measure, see, predict and make things on the scale of
atoms and molecules.
TBI, a non-profit organization committed to promoting the growth of
biotechnology in Toronto, brings together the worlds of research, government,
business and finance, and is one of the largest biotechnology organizations in
North America. The City of Toronto's Economic Development Division has
supported TBI from its inception as part of its continuing effort to enhance
the international competitiveness of the city's bio-medical industry.
The key note speaker was Dr. Uri Sagman, co-founder and president of C Sixty
Inc., a medical oncologist founder and the executive director of the Canadian
Nanobusiness Alliance, and Chairman of GRN Health International - a globally
based academic research organization.
Dr. Sagman described the implications of nanotechnology to biotechnology and
the life science sector through the research and development projects that his
company has undertaken.
"The direct application of nanoscale materials to biological targets is now
yielding promising applications in medicine," said Dr. Sagman. "We are moving
from the conceptual stage to the clinic and it's very exciting."